Clinical trial
Asymptomatic Bacterial Vaginosis and Herpes Simplex Virus Type 2 (BV/HSV-2)…
NCT00464542 · University of Pittsburgh, Other · Completed
Key facts
| NCT number | NCT00464542 |
|---|---|
| Title | Asymptomatic Bacterial Vaginosis and Herpes Simplex Virus Type 2 (BV/HSV-2) Shedding Study |
| Official title | Asymptomatic Bacterial Vaginosis and Herpes Simplex Virus Type 2 Shedding |
| Acronym | MASH |
| Lead sponsor | University of Pittsburgh, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Bacterial Vaginosis |
| Intervention type | Drug |
| Interventions | Metronidazole |
| Enrollment | 12 |
| Start date | Dec 1, 2007 |
| Primary completion | Mar 1, 2010 |
| Completion | Mar 1, 2010 |
| First posted | Apr 23, 2007 |
| Last update posted | May 11, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: